Regeneron Pharmaceuticals (REGN) Interest & Investment Income (2009 - 2016)
Regeneron Pharmaceuticals (REGN) reported Interest & Investment Income of $3.3 million for Q3 2016, up 54.3% from $2.14 million a year earlier and up 17.9% from the prior quarter.
Powered by 
Analysis
Regeneron Pharmaceuticals (REGN) Interest & Investment Income (2009 - 2016) Analysis & Trends
Over the twelve months ended Sep 30, 2016, Regeneron Pharmaceuticals' Interest & Investment Income came in at $10.49 million, up 85.7% year-over-year; for FY2013, it came in at -$231,000.
- By year, Interest & Investment Income came in at $2.01 million in FY2012 (-43.3%), $3.55 million in FY2011 (+67.2%), $2.12 million in FY2010 (-52.7%) and $4.49 million in FY2009.
- The Q3 2016 figure ranks as the highest quarterly Interest & Investment Income in data going back to Q2 2009.
- Year over year, Interest & Investment Income gained in two of the last four quarters, with growth averaging 10.4%.
- The high point for year-over-year Interest & Investment Income in five years was Q1 2014 (growth of 105.5%); the low point was Q1 2015 (a decline of 80.8%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,122.91 Bn | 1,091.50 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 615.09 Bn | 533.62 Bn | 17.26 Bn | 219.00 Mn |
| 3 | AbbVie | 504.75 Bn | 477.86 Bn | 12.70 Bn | - |
| 4 | Merck | 360.18 Bn | 314.55 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 292.05 Bn | 256.04 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 256.09 Bn | 229.78 Bn | 12.86 Bn | 80.00 Mn |
| 7 | Amgen | 233.63 Bn | 189.02 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 194.49 Bn | 168.69 Bn | 6.22 Bn | - |
| 9 | Pfizer | 168.35 Bn | 114.99 Bn | 10.94 Bn | - |
| 10 | Regeneron Pharmaceuticals | 81.27 Bn | 47.47 Bn | 3.71 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2016 | 3.30 Mn |
| Jun 30, 2016 | 2.80 Mn |
| Mar 31, 2016 | 2.25 Mn |
| Sep 30, 2015 | 2.14 Mn |
| Jun 30, 2015 | 1.65 Mn |
| Mar 31, 2015 | 180,000.00 |
| Jun 30, 2014 | 1.68 Mn |
| Mar 31, 2014 | 937,000.00 |
| Dec 31, 2013 | -2.26 Mn |
| Sep 30, 2013 | 618,000.00 |
| Jun 30, 2013 | 954,000.00 |
| Mar 31, 2013 | 456,000.00 |
| Dec 31, 2012 | 384,000.00 |
| Sep 30, 2012 | 517,000.00 |
| Jun 30, 2012 | 501,000.00 |
| Mar 31, 2012 | 610,000.00 |
| Dec 31, 2011 | 799,000.00 |
| Sep 30, 2011 | 715,000.00 |
| Jun 30, 2011 | 998,000.00 |
| Mar 31, 2011 | 1.04 Mn |
API Access
Regeneron Pharmaceuticals Interest & Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=REGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-and-investment-income", "ticker": "REGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=REGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();